Furthermore, phosphorylated ERK 1/2 levels correlate with JUNB-expression, suggesting that deregulated JUNB and MAPK activities are responsible for the malignant progression of CTCL [138]. Here, JUNB is linked to primary cutaneous T-cell non-Hodgkin lymphoma.